“Cost-Effectiveness of Pioglitazone in Patients With Type 2 Diabetes and a History of Macrovascular Disease in a Swiss Setting”. 2009. Swiss Medical Weekly 139 (1112): 173-73. https://doi.org/10.4414/smw.2009.12381.